Aquestive Therapeutics

Aquestive Therapeutics is a leading pharmaceutical company that specializes in developing and delivering medications through their innovative PharmFilm technology. With over 18 years of experience and more than 2 billion doses consumed, they are dedicated to advancing medicines and solving therapeutic problems to improve the lives of patients. Their pipeline of medicines aims to overcome barriers faced by patients with existing treatment options and provide new paradigms for treating critical and complex conditions.

As the worldwide leader in delivering trusted and quality medications on oral film, Aquestive follows a drug-by-drug approach to harness their PharmFilm technology, which offers optimized absorption, bioavailability, and onset of action. They are focused on reinventing medicines to improve treatment options for patients, particularly in the areas of central nervous system conditions and severe allergies, including anaphylaxis. With a strong intellectual property portfolio and a commitment to meaningful clinical and therapeutic advances, Aquestive is dedicated to advancing current standards of care through simplified and innovative delivery methods.

Generated from the website